“With GTP Bioways, Osivax found a reliable GMP-compliant formulation and aspetic filling service provider. Their understanding of our needs, commitment to quality and customer-oriented focus were appreciated. They are also our partners for some R&D and analytical activities with relevant and problem-solving scientific discussions”

Imène Turki, Osivax

“We are happy to work with GTP Bioways for our very first clinical trial. This collaboration is a key point in the preparation of our clinical product before its administration to patients. With their brand-new facilities in Toulouse and their aseptic fill and finish operations, GTP Bioways shows all the guarantees requested for our lead anticancer compound ABD-3001 during our first-in-human clinical trial in acute myeloid leukemia upcoming soon. During the set-up of our GMP production, GTP Bioways team has been quite flexible and reactive to our needs “

Ismail Ceylan, Founder and CEO of Advanced Biodesign

“At European Vaccine Initiative, we have found GTP Bioways to be a very reliable partner. I specifically appreciated the intelligence their team put in the process development, going beyond merely executing our instructions.”

Nicolas Havelange, EVI

“GTP Bioways is a flexible and reactive company with an high understanding of the development challenges for a biotech. Collaboration is easy, the teams are open to scientific discussions and collaborate with us about how to solve problems together. Very good partner for the development of new projects!”

Judith Greciet, Onxeo

“GTP Bioways is technically sound and client-oriented. We appreciated the mutual understanding between GTP Bioways and Xenothera and how GTP Bioways could adapt its offer to our needs.”

Bernard Vanhove, Xenothera